Javan Mohammad, Kazemi Bahram, Ahmadiani Abolhassan, Motamedi Fereshteh
Department of Physiology, School of Medical Sciences, Tarbiat Modarres Univ., Tehran, Iran.
Brain Res. 2006 Aug 9;1104(1):73-9. doi: 10.1016/j.brainres.2006.05.088. Epub 2006 Jul 7.
It is previously reported that the HPA axis plays role in the inhibitory effect of pain on tolerance development to analgesic effect of opioids. The present study was designed to investigate whether the chronic co-administration of dexamethasone as a glucocorticoid is also able to prevent or reverse analgesic tolerance to morphine and to compare the expression of G(alphai/o) and G(beta) subunits of G proteins in the context of chronic dexamethasone, development of morphine tolerance and their combination. Analgesic tolerance to morphine was induced by chronic intraperitoneally (i.p.) administration of morphine 20 mg/kg to male Wistar rats weighing 200-240 g within 4 consecutive days and analgesia was assessed using tail-flick test. Chronic dexamethasone was applied using 4 daily i.p. injections. Lumbar spinal tissues were assayed for the expression of G(alphai/o) and G(beta) proteins using "semiquantitative PCR" normalized to beta-actin gene expression. Results showed that chronic administration of dexamethasone could reduce and reverse the development of tolerance in rats that received chronic i.p. injections of morphine. Chronic administration of dexamethasone significantly increased the expression of G(alphai/o), while chronic administration of morphine did not change its expression. The expression of G(beta), however, was increased after the chronic administration of morphine, but did not change after the administration of chronic dexamethasone. None of these increases were observed when morphine and dexamethasone were co-administered. We conclude that the development of tolerance to analgesic effect of morphine could be prevented and reversed by dexamethasone co-administration. The increase in G(alphai/o) genes expression produced by chronic dexamethasone may facilitate the opioid signaling pathway and compensate for morphine-induced tolerance.
先前有报道称,下丘脑-垂体-肾上腺(HPA)轴在疼痛对阿片类药物镇痛效果耐受性发展的抑制作用中发挥作用。本研究旨在调查作为糖皮质激素的地塞米松长期联合给药是否也能够预防或逆转对吗啡的镇痛耐受性,并比较在长期使用地塞米松、吗啡耐受性发展及其联合使用的情况下,G蛋白的G(αi/o)和G(β)亚基的表达。通过对体重200 - 240克的雄性Wistar大鼠连续4天腹腔内(i.p.)注射20毫克/千克吗啡来诱导对吗啡的镇痛耐受性,并使用甩尾试验评估镇痛效果。通过每天4次腹腔内注射应用长期地塞米松。使用以β-肌动蛋白基因表达标准化的“半定量PCR”测定腰段脊髓组织中G(αi/o)和G(β)蛋白的表达。结果表明,长期给予地塞米松可以减少并逆转接受长期腹腔内注射吗啡的大鼠的耐受性发展。长期给予地塞米松显著增加了G(αi/o)的表达,而长期给予吗啡并未改变其表达。然而,长期给予吗啡后G(β)的表达增加,但长期给予地塞米松后其表达没有变化。当吗啡和地塞米松联合给药时,未观察到这些增加。我们得出结论,联合给予地塞米松可以预防和逆转对吗啡镇痛效果的耐受性发展。长期地塞米松引起的G(αi/o)基因表达增加可能促进阿片类信号通路并补偿吗啡诱导的耐受性。